Cardiff Oncology
Stock Forecast, Prediction & Price Target
Cardiff Oncology Financial Estimates
Cardiff Oncology Revenue Estimates
Cardiff Oncology EBITDA Estimates
Cardiff Oncology Earnings per Share Estimates
| Passed | Analyst forecast | ||||||
|---|---|---|---|---|---|---|---|
| Metric | 12/31/2021 | 12/31/2022 | 12/31/2023 | 12/31/2025 | 12/31/2026 | 12/31/2027 | 12/31/2028 |
Revenue
% change YoY
| $359K N/A | $386K 7.52% | $488K 26.42% | Avg: $66.67K Low: $38.09K High: $114.92K avg. -86.33% | Avg: $66.67K Low: $38.09K High: $114.92K avg. 0% | Avg: $66.66K Low: $38.09K High: $114.92K avg. -0.00% | Avg: $100K Low: $57.14K High: $172.38K avg. 49.99% |
Net Income
% change YoY
| $-27.74M N/A | $-37.50M -35.19% | $-41.44M -10.49% | Avg: $-57.90M Low: $-53.16M High: $-35.74M avg. -39.73% | Avg: $-78.14M Low: $-68.80M High: $-51.37M avg. -34.93% | Avg: $-85.11M Low: $-165.20M High: $-37.69M avg. -8.92% | Avg: $-99.40M Low: $-192.94M High: $-44.02M avg. -16.78% |
EBITDA
% change YoY
| $-28.68M N/A | $-39.66M -38.26% | $-45.01M -13.48% | Avg: $-66.67K Low: $-114.92K High: $-38.09K avg. 99.85% | Avg: $-66.67K Low: $-114.92K High: $-38.09K avg. 0% | Avg: $-66.66K Low: $-114.92K High: $-38.09K avg. 0.00% | Avg: $-100K Low: $-172.38K High: $-57.14K avg. -49.99% |
EPS
% change YoY
| -$0.71 N/A | -$0.86 -21.12% | -$0.93 -8.13% | Avg: -$1.06 Low: -$1.19 High: -$0.8 avg. -13.97% | Avg: -$1.33 Low: -$1.54 High: -$1.15 avg. -25.47% | Avg: -$1.91 Low: -$3.7 High: -$0.84 avg. -43.24% | Avg: -$2.23 Low: -$4.32 High: -$0.99 avg. -16.78% |
Operating Expenses
% change YoY
| $29.21M N/A | $40.28M 37.90% | $45.9M 13.92% | Avg: $1.85M Low: $1.05M High: $3.19M avg. -95.96% | Avg: $1.85M Low: $1.05M High: $3.19M avg. 0% | Avg: $1.85M Low: $1.05M High: $3.19M avg. -0.00% | Avg: $2.77M Low: $1.58M High: $4.79M avg. 49.99% |
FAQ
What is Cardiff Oncology stock earnings growth forecast?
Wall Street analysts estimate the annual average earnings growth rate of -25.09% in 2025-2028.
We have gathered data from 3 analysts. Their low estimate is -53.16M, average is -57.90M and high is -35.74M.
What is Cardiff Oncology stock revenue growth forecast?
Wall Street analysts forecast annual average revenue growth of -9.08% in 2025-2028.
We have gathered data from 2 analysts. Their low revenue estimate is $38.09K, average is $66.67K and high is $114.92K.
What is Cardiff Oncology stock earnings per share growth forecast?
Wall Street analysts forecast annual average earnings growth of -24.87% in 2025-2028.
We have gathered data from 3 analysts. Their low earnings per share estimate is -$1.19, average is -$1.06 and high is $-0.8.
What is the best performing analyst?
In the last twelve months analysts have been covering Cardiff Oncology stock. The most successful analyst is Joseph Catanzaro.